HER2 Targeting in Early Breast Cancer: More Options and More Questions

od LEMBERSKY, BARRY C., RASTOGI, PRIYA
Wydane w Oncology (Williston Park) (2014)

Randomized Psychosocial Interventions for Breast Cancer: Impact on Life Purpose

od Mens, Maria G., Helgeson, Vicki S., Lembersky, Barry C., Baum, Andrew, Scheier, Michael F.
Wydane w Psychooncology (2015)

Risedronate Prevents Bone Loss in Breast Cancer Survivors: A 2-Year, Randomized, Double-Blind, Placebo-Controlled Clinical Trial

od Greenspan, Susan L., Brufsky, Adam, Lembersky, Barry C., Bhattacharya, Rajib, Vujevich, Karen T., Perera, Subashan, Sereika, Susan M., Vogel, Victor G.
Wydane 2008

Outcomes with FOLFIRINOX for Borderline Resectable and Locally Unresectable Pancreatic Cancer

od Boone, Brian A., Steve, Jennifer, Krasinskas, Alyssa M., Zureikat, Amer H., Lembersky, Barry C., Gibson, Michael K., Stoller, Ronald, Zeh, Herbert J., Bahary, Nathan
Wydane 2013

Prevention of Bone Loss with Risedronate in Breast Cancer Survivors: A Randomized, Controlled Clinical Trial

od Greenspan, Susan L., Vujevich, Karen T., Brufsky, Adam, Lembersky, Barry C., van Londen, G.J., Jankowitz, Rachel C., Puhalla, Shannon L., Rastogi, Priya, Perera, Subashan
Wydane w Osteoporos Int (2015)

Polymorphisms in DNA repair and oxidative stress genes associated with pre-treatment cognitive function in breast cancer survivors: an exploratory study

od Koleck, Theresa A., Bender, Catherine M., Sereika, Susan M., Brufsky, Adam M., Lembersky, Barry C., McAuliffe, Priscilla F., Puhalla, Shannon L., Rastogi, Priya, Conley, Yvette P.
Wydane w Springerplus (2016)

Body mass index at diagnosis and breast cancer survival prognosis in clinical trial populations from NRG Oncology/NSABP B-30, B-31, B-34, and B-38

od Cecchini, Reena S., Swain, Sandra M., Costantino, Joseph P., Rastogi, Priya, Jeong, Jong-Hyeon, Anderson, Stewart J., Tang, Gong, Geyer, Charles E., Lembersky, Barry C., Romond, Edward H., Paterson, Alexander H.G., Wolmark, Norman
Wydane w Cancer Epidemiol Biomarkers Prev (2015)

21-Gene Recurrence Score and Locoregional Recurrence in Node-Positive/ER-Positive Breast Cancer Treated With Chemo-Endocrine Therapy

od Mamounas, Eleftherios P., Liu, Qing, Paik, Soonmyung, Baehner, Frederick L., Tang, Gong, Jeong, Jong-Hyeon, Kim, S. Rim, Butler, Steven M., Jamshidian, Farid, Cherbavaz, Diana B., Sing, Amy P., Shak, Steven, Julian, Thomas B., Lembersky, Barry C., Wickerham, D. Lawrence, Costantino, Joseph P., Wolmark, Norman
Wydane w J Natl Cancer Inst (2017)

21-Gene Recurrence Score for prognosis and prediction of taxane benefit after adjuvant chemotherapy plus endocrine therapy: Results from NSABP B-28/NRG Oncology

od Mamounas, Eleftherios P., Tang, Gong, Paik, Soonmyung, Baehner, Frederick L., Liu, Qing, Jeong, Jong-Hyeon, Kim, Seong-Rim, Butler, Steven M., Jamshidian, Farid, Cherbavaz, Diana B., Sing, Amy P., Shak, Steven, Julian, Thomas B., Lembersky, Barry C., Wickerham, D. Lawrence, Costantino, Joseph P., Wolmark, Norman
Wydane w Breast Cancer Res Treat (2017)

Oral clodronate for adjuvant treatment of operable breast cancer (National Surgical Adjuvant Breast and Bowel Project protocol B-34): a multicentre, placebo-controlled, randomised...

od Paterson, Alexander H G, Anderson, Stewart J, Lembersky, Barry C, Fehrenbacher, Louis, Falkson, Carla I, King, Karen M, Weir, Lorna M, Brufsky, Adam M, Dakhil, Shaker, Lad, Thomas, Baez-Diaz, Luis, Gralow, Julie R, Robidoux, André, Perez, Edith A, Zheng, Ping, Geyer, Charles E, Swain, Sandra M, Costantino, Joseph P, Mamounas, Eleftherios P, Wolmark, Norman
Wydane w Lancet Oncol (2012)

A randomized trial of five years of letrozole versus placebo after aromatase inhibitor-based therapy: NRG Oncology/NSABP B-42

od Mamounas, Eleftherios P., Bandos, Hanna, Lembersky, Barry C., Jeong, Jong-Hyeon, Geyer, Charles E., Rastogi, Priya, Fehrenbacher, Louis, Graham, Mark L., Chia, Stephen K., Brufsky, Adam M., Walshe, Janice M., Soori, Gamini S., Dakhil, Shaker R., Seay, Thomas E., Wade, James L., McCarron, Edward C., Paik, Soonmyung, Swain, Sandra M., Lawrence Wickerham, D., Wolmark, Norman
Wydane w Lancet Oncol (2018)